Trademark: 79168175
Word
AUTOLUS
Status
Dead
Status Code
709
Status Date
Friday, October 7, 2022
Serial Number
79168175
Registration Number
4920212
Registration Date
Tuesday, March 22, 2016
Mark Type
4000
Filing Date
Thursday, April 16, 2015
Published for Opposition
Tuesday, January 5, 2016
Cancellation Date
Friday, October 7, 2022

Trademark Owner History
Autolus Limited - Original Registrant
Autolus Limited C-O Syncona Partners - Owner At Publication

Classifications
5 Medical and veterinary preparations, namely, engineered T-cells for therapeutic purposes; preparations for cell therapy, namely, engineered T-cells; preparations for gene therapy, namely, engineered T-cells; biological preparations for cancer therapies; medical preparations, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes
44 Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
42 Scientific and technological services and research and design relating thereto, namely, scientific research; industrial analysis and research services in the field of T-cells and chimeric antigen receptors; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services

Trademark Events
Jun 7, 2023
Total Invalidation Of Reg Ext Protection Created
Oct 7, 2022
Cancelled Section 71
Oct 3, 2021
Change Of Name/Address Rec'd From Ib
Mar 22, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 15, 2016
Final Decision Transaction Processed By Ib
Jun 23, 2016
Final Disposition Notice Sent To Ib
Jun 23, 2016
Final Disposition Processed
Jun 22, 2016
Final Disposition Notice Created, To Be Sent To Ib
Apr 8, 2016
Correction From Ib Entered - No Review Required
Apr 1, 2016
Correction Transaction Received From Ib
Mar 22, 2016
Registered-Principal Register
Jan 5, 2016
Official Gazette Publication Confirmation E-Mailed
Jan 5, 2016
Published For Opposition
Jan 4, 2016
Notification Processed By Ib
Dec 16, 2015
Notification Of Possible Opposition Sent To Ib
Dec 16, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 16, 2015
Notification Of Notice Of Publication E-Mailed
Nov 28, 2015
Approved For Pub - Principal Register
Nov 23, 2015
Teas/Email Correspondence Entered
Nov 23, 2015
Correspondence Received In Law Office
Nov 23, 2015
Teas Response To Office Action Received
Aug 22, 2015
Refusal Processed By Ib
Aug 6, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Aug 6, 2015
Refusal Processed By Mpu
Aug 6, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Aug 5, 2015
Non-Final Action Written
Jul 27, 2015
Assigned To Examiner
Jul 10, 2015
Application Filing Receipt Mailed
Jul 6, 2015
New Application Office Supplied Data Entered
Jul 2, 2015
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24